HomeNewsArticle Display

Operational testers unite in solution for transporting COVID-19 patients

AFOTEC’s Detachment 2 test team, lead by Maj. Phillip Hoyt, is at Joint Base Charleston, South Carolina testing the Portable Bio-Containment Module (PBCM) on airworthiness requirements on the C-17 aircraft along with several other key areas during this Joint Urgent Operational Need testing event. PBCM is an existing capability currently being used by the Department of State. With the urgent need to transport as many as 4,000 American citizens from overseas per month, PBCM is one of many options the Air Force is considering to transport infectious patients. This testing is just one of a series of testing that AFOTEC is conducting to support the current COVID-19 pandemic.

AFOTEC’s Detachment 2 test team, lead by Maj. Phillip Hoyt, is at Joint Base Charleston, South Carolina testing the Portable Bio-Containment Module (PBCM) on airworthiness requirements on the C-17 aircraft along with several other key areas during this Joint Urgent Operational Need testing event. PBCM is an existing capability currently being used by the Department of State. With the urgent need to transport as many as 4,000 American citizens from overseas per month, PBCM is one of many options the Air Force is considering to transport infectious patients. This testing is just one of a series of testing that AFOTEC is conducting to support the current COVID-19 pandemic.

Victor Arca, 28th Test and Evaluation Squadron senior test engineer, and Gabriel Intano, Army Public Health Center microbiologist, collect data while performing testing on a Portable Bio-Containment Module loaded onto a C-17 Globemaster III at Joint Base Charleston S.C., April 15, 2020. Members from the 28th TES and Army PHC tested the PBCM, which will be exercised regularly to transport COVID patients and medical personnel, all while ensuring the aircrew is impervious to risk of infection. (U.S. Air Force photo by Staff Sgt. Chris Drzazgowski)

Victor Arca, 28th Test and Evaluation Squadron senior test engineer, and Gabriel Intano, Army Public Health Center microbiologist, collect data while performing testing on a Portable Bio-Containment Module loaded onto a C-17 Globemaster III at Joint Base Charleston S.C., April 15, 2020. Members from the 28th TES and Army PHC tested the PBCM, which will be exercised regularly to transport COVID patients and medical personnel, all while ensuring the aircrew is impervious to risk of infection. (U.S. Air Force photo by Staff Sgt. Chris Drzazgowski)

Operational testers from across the Department of Defense to test the Portable Bio-Containment Module on a C-17 Globemaster III at Joint-Base Charleston, S.C.

Operational testers from across the Department of Defense to test the Portable Bio-Containment Module on a C-17 Globemaster III at Joint-Base Charleston, S.C.

Members of the Portable Bio-Chemical Module test team prepare to load a patient.

Members of the Portable Bio-Chemical Module test team prepare to load a patient.

Members from the Portable Bio-Chemical Module team test communication inside and outside of the module.

Members from the Portable Bio-Chemical Module team test communication inside and outside of the module.

The Transportable Isolation System is a palletized system initially designed to transport patients during the Ebola epidemic.

The Transportable Isolation System is a palletized system initially designed to transport patients during the Ebola epidemic.

KIRTLAND AIR FORCE BASE, N.M. -- Operational testers unite in solution for safely transporting COVID-19 patients on military aircraft Operational test experts from across the Department of Defense are working together in the fight to overcome a worldwide adversary – COVID-19. The Air Force Operational Test and Evaluation Center (AFOTEC) is partnering with more than a dozen other organizations in response to the U.S. Transportation Command’s request for a Joint Urgent Operational Need (JUON) for safely transporting COVID-19 patients within isolation pods on military cargo aircraft.

During 2014 through 2015, U.S. forces were deployed to assist in the mitigation of the humanitarian crises in West Africa due to the Ebola epidemic. AFOTEC joined with many of its current partners to conduct testing on a Transportable Isolation System. TIS is a palletized system that is made from existing protection equipment that consists of a clear plastic fabric hung from a metal structure enclosed with an associated blower and filter system. TIS can transport two to seven patients depending on their medical needs. However, TIS was not designed for the transport of airborne virus patients such as COVID-19.

With the urgent need to transport as many as 4,000 American citizens from overseas per month, the Portable Bio-Chemical Module (PBCM) is one of several options the Air Force is considering to transport infectious patients. PBCM is an existing capability currently used by the Department of State. The PBCM is a hard roll-on-roll-off structure that holds four patients. The Air Force Life Cycle Management Center (AFLCMC) is also developing its own solutions to carry a higher quantity of patients in the Negative Pressure Containment (NPC) module. The NPC, which will be tested immediately after PBCM, is a shipping container structure designed to transport more than 30 patients on a C-17. NPC-lite will follow NPC and is intended for C-130 transport and multi-service use.

The PBCM Operational Utility Evaluation started toward the end of March. AFOTEC’s Detachment 2 test team from Eglin AFB, Fla., led by Maj. Phillip Hoyt, deployed with key experts to meet with Air Mobility Command Headquarters and Joint Base Charleston operations personnel. As the test director, Major Hoyt was center point in ensuring the entire united test team was synced for this JUON. During the first week, the team’s focus shifted to first helping to solve TIS deficiencies that restricted the system from supporting immediate operations with COVID-19 infected patients. The team was then tasked by the AMC Surgeon General to develop new decontamination procedures to allow greater TIS mission flexibility and quicker turn times. By the end of the first week the team was supporting the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO CBRND), headquartered at Aberdeen Proving Ground, Md., in structuring a JUON for the NPC to transport large numbers of patients. The new procedures were immediately put into place on operational missions.

Current PBCM OUE testing is focused on airworthiness requirements, biocontainment testing, concept of operations (CONOPS) development, medical crew familiarization, and flight testing on the C-17 with operational crews. Upon conclusion of PBCM testing, the team will immediately pivot to completing the same testing on NPC and the NPC-lite variant.

“The need to expeditiously field the system requires a synergistic approach,” said Major Hoyt, AFOTEC Detachment 2 Test Director. “The test team is adjusting execution to ensure valid data collection and operational realism. The test execution period, while it may appear to be condensed, is the same process used in other operational testing with the exception that several events are accomplished in parallel.” According to Hoyt, the approach is technically adequate to address all user requirements and determine the system's effectiveness, suitability and mission capability.

AFOTEC’s test team includes a bioenvironmental engineer, bioenvironmental technician, and emergency management testers who work out of Detachment 2’sCBRN Test Branch. AFOTEC’s test team, along with other agencies, is combining and conducting concurrent test design, test planning and test execution efforts and events to shorten the total time required to complete test process. While this is normally a process done sequentially by a single test team, several test teams are joining together in a joint effort to accomplish events concurrently.

The multi-agency test team includes the JPEO CBRND that took management of PBCM and NPC at the end of March. Key to program success is a “safe-to-fly” certification on the C-17 and this requires intense efforts from the C-17 System Program Office at Robins AFB, Ga., and the 28th Test and Evaluation Squadron at Eglin. Additionally, the capability of the systems to contain an aerosol virus requires sophisticated sampling and collection methods specifically designed for the system and flight environment. This expertise is provided by Dr. Josh Santarpia at the University of Nebraska Medical Center; Dr. Jana Kesavan from the U.S. Army Combat Capabilities Development Command Chemical Biological Center; Dr. Gabriel Intano at the U.S. Army Public Health Center Environmental Health Risk Assessment Division; and Dr. Doug Lewis from the 711th Human Performance Wing at Wright-Patterson AFB, Ohio. The CONOPS and procedures developed for containment, patient care, and operations is provided by the Air Force Materiel Command Centers for Sustainment of Trauma and Readiness Skills Omaha, the AMC Surgeon General, and AMC Operations, Plans and Requirements personnel. JB Charleston operations and support personnel are providing the location to make the test happen.

This collaboration of operational testers allows the Department of Defense to expand the scope of effort to increase flexibility and speed to answer the call supporting the fight to defeat COVID-19. “The dedicated commitment of this entire test team is necessary to complete testing on a timeline rarely seen to confront the significant COVID-19 health risks,” said Col. Timothy J. Stevens, AFOTEC Detachment 2 Commander.

“The joint test team is pushing very hard to complete a test effort that usually takes months of planning and execution in a few weeks because the threat this virus poses to Americans and military members world-wide is real,” said Colonel Stevens. “They need a way to get safely home for treatment while we mitigate the threat to our aircrews and medical personnel.”